Výsledky vyhledávání - Lassen, U
- Zobrazuji výsledky 1 - 11 z 11
-
1
-
2
-
3
-
4
A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours Autor Lassen, U, Nielsen, D L, Sørensen, M, Winstedt, L, Niskanen, T, Stenberg, Y, Pakola, S, Stassen, J-M, Glazer, S
Vydáno 2012Text -
5
P17.91 CLINICAL VARIABLES SERVE AS PREDICTIVE FACTORS IN A MODEL FOR CLINICAL RESPONSE TO BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME: AN OBSERVATIONAL STUDY OF A COHORT OF CO... Autor Urup, T., Grunnet, K., Christensen, I.J., Michaelsen, S.R., Broholm, H., Stockhausen, M.T., Lassen, U., Poulsen, H.S.
Vydáno 2014Text -
6
P08.06 Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients Autor Urup, T., Staunstrup, L., Michaelsen, S., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Broholm, H., Hamerlik, P., Poulsen, H., Lassen, U.
Vydáno 2016Text -
7
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with s... Autor Lassen, U, Molife, L R, Sorensen, M, Engelholm, S-A, Vidal, L, Sinha, R, Penson, R T, Buhl-Jensen, P, Crowley, E, Tjornelund, J, Knoblauch, P, de Bono, J S
Vydáno 2010Text -
8
A Comparison of Endoscopic Ultrasound Guided Biopsy and Positron Emission Tomography with Integrated Computed Tomography in Lung Cancer Staging Autor Larsen, S.S., Vilmann, P., Krasnik, K., Dirksen, Asger, Clementsen, P., Skov, Birgit G., Jacobsen, Grete Krag, Lassen, U., Eigtved, Annika, Berthelsen, Anne Kiil, Mortensen, J., Hoejgaard, Liselotte
Vydáno 2009Text -
9
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma Autor Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C, Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A., Massard, Christophe
Vydáno 2019Text -
10
OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial Autor Dietrich, P, Wick, W, Hilf, N, Frenzel, K, Gouttefangeas, C, Platten, M, thor Straten, P, Lassen, U, Rodon, J, Bukur, V, Admon, A, van der Burg, S H, von Deimling, A, Kroep, J R, Martinez-Ricarte, F, Okada, H, Ottensmeier, C H, Ponsati, B, Poulsen, H S, Stevanovic, S, Tabatabai, G, Rammensee, H, Sahin, U, Singh-Jasuja, H
Vydáno 2018Text -
11
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children Autor Drilon, A., Laetsch, T.W., Kummar, S., DuBois, S.G., Lassen, U.N., Demetri, G.D., Nathenson, M., Doebele, R.C., Farago, A.F., Pappo, A.S., Turpin, B., Dowlati, A., Brose, M.S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W.S., Baik, C., Deeken, J., Boni, V., Nagasubramanian, R., Taylor, M., Rudzinski, E.R., Meric-Bernstam, F., Sohal, D.P.S., Ma, P.C., Raez, L.E., Hechtman, J.F., Benayed, R., Ladanyi, M., Tuch, B.B., Ebata, K., Cruickshank, S., Ku, N.C., Cox, M.C., Hawkins, D.S., Hong, D.S., Hyman, D.M.
Vydáno 2018Text